Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NBI-12i: MC4-R antagonist studied for cachexia treatment

July 7, 2005

Prous Science announces publication of a comprehensive review on cachexia

July 7, 2005

Therapeutic benefits of Oral-lyn insulin spray in diabetes

July 7, 2005

New agents for metabolic diseases reported in recent patents

July 7, 2005

Tesaglitazar improves lipid and glucose parameters of diabetic and insulin-resistant patients

July 6, 2005

Exubera inhaled insulin reported safe and effective in diabetes

July 6, 2005

New data on the efficacy of DX-88 in hereditary angioedema

July 6, 2005

Depo-Provera reported to induce changes in bone mineral density of women

July 6, 2005

Osteoprotegerin blocks lytic cancer lesions in bones

July 6, 2005

Acrux receives license fee from Vivus for Evamist

July 6, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...